Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Rauh

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Journal of Medicinal Chemistry|August 15, 2015
Targeting Drug Resistance in EGFR with Covalent Inhibitors: A Structure-Based Design ApproachJulian Engel, André Richters, Matthäus Getlik, et al.
Cell|July 4, 2015
A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant CancerFelix Dietlein, Bastian Kalb, Mladen Jokic, et al.
Journal of Medicinal Chemistry|April 29, 2022
Insight into Targeting Exon20 Insertion Mutations of the Epidermal Growth Factor Receptor with Wild Type-Sparing InhibitorsJonas Lategahn, Hannah L Tumbrink, Carsten Schultz-Fademrecht, et al.
Journal for Immunotherapy of Cancer|April 7, 2023
Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanomaLuiza Martins Nascentes Melo, Dayana Herrera-Rios, Daniel Hinze, et al.
Chemical Science|December 21, 2019
Inhibition of osimertinib-resistant epidermal growth factor receptor EGFR-T790M/C797SJonas Lategahn, Marina Keul, Philip Klövekorn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2024
KIT ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor: Emerging Mechanisms of Kinase Inhibitor EscapeThomas Mühlenberg, Johanna Falkenhorst, Tom Schulz, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancerMartin L Sos, Stefanie Fischer, Roland Ullrich, et al.
Cancer & Metabolism|December 10, 2022
Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinomaIrina Heid, Corinna Münch, Sinan Karakaya, et al.
Cancer Research|March 13, 2019
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in <i>KRAS</i>-Mutant Pancreatic and Colorectal CancerJörn Weisner, Ina Landel, Christoph Reintjes, et al.
Cancer Discovery|December 5, 2013
Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancerFlorian Malchers, Felix Dietlein, Jakob Schöttle, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Journal of Medicinal Chemistry|August 15, 2015
Targeting Drug Resistance in EGFR with Covalent Inhibitors: A Structure-Based Design ApproachJulian Engel, André Richters, Matthäus Getlik, et al.
Cell|July 4, 2015
A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant CancerFelix Dietlein, Bastian Kalb, Mladen Jokic, et al.
Journal of Medicinal Chemistry|April 29, 2022
Insight into Targeting Exon20 Insertion Mutations of the Epidermal Growth Factor Receptor with Wild Type-Sparing InhibitorsJonas Lategahn, Hannah L Tumbrink, Carsten Schultz-Fademrecht, et al.
Journal for Immunotherapy of Cancer|April 7, 2023
Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanomaLuiza Martins Nascentes Melo, Dayana Herrera-Rios, Daniel Hinze, et al.
Chemical Science|December 21, 2019
Inhibition of osimertinib-resistant epidermal growth factor receptor EGFR-T790M/C797SJonas Lategahn, Marina Keul, Philip Klövekorn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2024
KIT ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor: Emerging Mechanisms of Kinase Inhibitor EscapeThomas Mühlenberg, Johanna Falkenhorst, Tom Schulz, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancerMartin L Sos, Stefanie Fischer, Roland Ullrich, et al.
Cancer & Metabolism|December 10, 2022
Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinomaIrina Heid, Corinna Münch, Sinan Karakaya, et al.
Cancer Research|March 13, 2019
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in <i>KRAS</i>-Mutant Pancreatic and Colorectal CancerJörn Weisner, Ina Landel, Christoph Reintjes, et al.
Cancer Discovery|December 5, 2013
Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancerFlorian Malchers, Felix Dietlein, Jakob Schöttle, et al.
Pageof 16